
zzso zzso infections are one of the leading causes of morbidity and mortality in cancer zzso zzso B zzso is still considered the gold standard of zzso therapy, although the new zzso zzso and, especially, zzso have shown to be able to replace zzso B for some therapeutic zzso The new zzso zzso of zzso B have disclosed new therapeutic perspectives, especially in patients with severe zzso failure and zzso zzso At this time, zzso zzso and limitation of the various drugs in the zzso zzso are still partially zzso zzso prophylaxis with zzso may be indicated in high-risk patients, although the duration of such prophylaxis should be limited as much as possible, in order to prevent selection of resistant strains and acquired zzso zzso zzso therapy is used extremely widely zzso too zzso in many cancer zzso despite being based on limited clinical zzso For this indication, zzso may also be effective in patients not receiving zzso zzso in whom zzso infection is zzso 

